Peijia Medical Limited - Asset Resilience Ratio

Latest as of December 2025: 0.51%

Peijia Medical Limited (4WO) has an Asset Resilience Ratio of 0.51% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€13.53 Million
≈ $15.82 Million USD Cash + Short-term Investments

Total Assets

€2.66 Billion
≈ $3.11 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Peijia Medical Limited's Asset Resilience Ratio has changed over time. Check 4WO strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Peijia Medical Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Peijia Medical Limited market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €13.53 Million 0.51%
Total Liquid Assets €13.53 Million 0.51%

Asset Resilience Insights

  • Limited Liquidity: Peijia Medical Limited maintains only 0.51% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Peijia Medical Limited Industry Peers by Asset Resilience Ratio

Compare Peijia Medical Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Novocure Ltd
NASDAQ:NVCR
Medical Devices 43.72%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
Medical Devices 10.88%
Bactiguard Holding AB (publ)
ST:BACTI-B
Medical Devices 8.12%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%

Annual Asset Resilience Ratio for Peijia Medical Limited (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Peijia Medical Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.51% €13.53 Million
≈ $15.82 Million
€2.66 Billion
≈ $3.11 Billion
-1.19pp
2024-12-31 1.70% €45.78 Million
≈ $53.53 Million
€2.69 Billion
≈ $3.14 Billion
-3.80pp
2023-12-31 5.51% €147.16 Million
≈ $172.04 Million
€2.67 Billion
≈ $3.12 Billion
+3.35pp
2022-12-31 2.16% €71.56 Million
≈ $83.67 Million
€3.32 Billion
≈ $3.88 Billion
+2.04pp
2020-12-31 0.11% €3.26 Million
≈ $3.81 Million
€2.88 Billion
≈ $3.37 Billion
-1.59pp
2019-12-31 1.71% €15.00 Million
≈ $17.54 Million
€879.48 Million
≈ $1.03 Billion
--
pp = percentage points

About Peijia Medical Limited

F:4WO Germany Medical Devices
Market Cap
$328.75 Million
€281.20 Million EUR
Market Cap Rank
#14275 Global
#1440 in Germany
Share Price
€0.42
Change (1 day)
+0.00%
52-Week Range
€0.39 - €1.01
All Time High
€3.90
About

Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products inc… Read more